{"company_name": "SUNPHARMA LTD", "extracted_text": "No significant corporate developments for SUNPHARMA Ltd on 22.08.2025 . News coverage on that date consisted of routine stock price movements and market commentary.\n\nMajor corporate announcements for SUNPHARMA in August 2025 include:\n\nApproval for Phase III clinical study:The Subject Expert Committee of India's drug regulator granted approval for a Phase III clinical study of Ruxolitinib cream for treating non-segmental vitiligo.\n\nAnalyst/investor meetings:SUNPHARMA held scheduled analyst and investor meetings on August 12 and August 25.\n\nQ1 FY26 earnings call transcript:The transcript for the first quarter of fiscal year 2026 earnings call was made public on August 6.\n\nRegulatory response:On August 1 and 6, SUNPHARMA issued clarifications to stock exchanges regarding the potential impact of US tariff concerns, stating that there was no company-specific development affecting the share price.", "links_raw": "1. https://www.angelone.in/live-blog/sun-pharmaceutical-industries-ltd-22-aug-2025-524715#:~:text=Sun%20Pharmaceutical%20Industries%20Ltd%20Stock,22%2C%202025%203:15%20PM\n2. https://www.angelone.in/live-blog/sun-pharmaceutical-industries-ltd-22-aug-2025-524715#:~:text=Solid%20Jump%20for%20Sun%20Pharmaceutical,22%2C%202025%2010:45%20AM\n3. https://www.moneycontrol.com/news/business/stocks/sun-pharmaceutical-industries-shares-fall-2-01-in-today-s-trading-session-alpha-article-13495103.html#:~:text=Sun%20Pharmaceutical%20Industries%20announced%20several,date%20of%20November%2026%2C%202010.\n4. https://sunpharma.com/wp-content/uploads/2025/08/SEintimationformarketrumours.pdf\n5. https://medicaldialogues.in/news/industry/pharma/cdsco/sun-pharma-wins-cdsco-panel-approval-for-phase-iii-vitiligo-trial-of-ruxolitinib-cream-154037#:~:text=New%20Delhi:%20Based%20on%20the,responsible%20for%20producing%20skin%20pigment.\n6. https://nsearchives.nseindia.com/corporate/SUNSEC_06082025133654_Reply_to_NSE.pdf", "processed_links": ["https://1. https://www.angelone.in/live-blog/sun-pharmaceutical-industries-ltd-22-aug-2025-524715#:~:text=Sun%20Pharmaceutical%20Industries%20Ltd%20Stock", "https://22%2C%202025%203:15%20PM\n2. https://www.angelone.in/live-blog/sun-pharmaceutical-industries-ltd-22-aug-2025-524715#:~:text=Solid%20Jump%20for%20Sun%20Pharmaceutical", "https://22%2C%202025%2010:45%20AM\n3. https://www.moneycontrol.com/news/business/stocks/sun-pharmaceutical-industries-shares-fall-2-01-in-today-s-trading-session-alpha-article-13495103.html#:~:text=Sun%20Pharmaceutical%20Industries%20announced%20several", "https://date%20of%20November%2026%2C%202010.\n4. https://sunpharma.com/wp-content/uploads/2025/08/SEintimationformarketrumours.pdf\n5. https://medicaldialogues.in/news/industry/pharma/cdsco/sun-pharma-wins-cdsco-panel-approval-for-phase-iii-vitiligo-trial-of-ruxolitinib-cream-154037#:~:text=New%20Delhi:%20Based%20on%20the", "https://responsible%20for%20producing%20skin%20pigment.\n6. https://nsearchives.nseindia.com/corporate/SUNSEC_06082025133654_Reply_to_NSE.pdf"], "date": "2025-08-22"}